Dear John,

FYI, through Saturday, July 20, we are having a flash sale on Health Affairs Insider membership. Use the code HealthWonkLife for $30 off the normal Insider price.

Today's Featured Articles

From the Journal: National Health Expenditure Projections, 2023–32: Payer Trends Diverge As Pandemic-Related Policies Fade

Jacqueline A. Fiore et al.

Forefront: Supreme Court Overrules Chevron Doctrine: Ripple Effects Across Health Care

Zachary Baron et al.

Forefront: Reconsidering Pharmacy Methadone Distribution For Opioid Use Disorders

Naba Husain

New Alzheimer's Drug Approval Expands Treatment Options — and Creates Coverage Questions

Health Affairs' Jeff Byers welcomes Senior Editor Leslie Erdelack to the program to discuss the FDA's recent approval of an Alzheimer's treatment, Lilly’s Kisunla; how private insurers and Medicare might cover the drug; and the emerging new class of drugs surrounding Alzheimer's treatment.

Health Affairs Scholar is celebrating its one-year anniversary.

The digital journal published its first issue in July 2023 with a dedication to emerging policy trends and global health.

Its presence is growing. Cited by Congress and national media outlets like the New York Times, NPR, and the Los Angeles Times, Scholar has published papers on health care costs, access, quality, and equity. High-impact papers have included:

• Active steps to reduce administrative spending associated with financial transactions in US health care
• Food and Drug Administration novel drug decisions in 2017: transparency and disclosure prior to and 5 years following approval
• Has the fall of Roe changed contraceptive access and use? New research from four US states offers critical insights

Read about Scholar’s first year from Editor-in-Chief Kathryn Phillips on Forefront.

Also, check out a Health Affairs Scholar editorial from Phillips as well.